{"id":65858,"date":"2026-05-18T19:36:25","date_gmt":"2026-05-18T16:36:25","guid":{"rendered":"https:\/\/entarabi.com\/?p=65858"},"modified":"2026-05-18T19:40:50","modified_gmt":"2026-05-18T16:40:50","slug":"uaes-mgx-joins-2-1b-funding-round-for-ai-isomorphic-labs","status":"publish","type":"post","link":"https:\/\/entarabi.com\/en\/2026\/05\/uaes-mgx-joins-2-1b-funding-round-for-ai-isomorphic-labs\/","title":{"rendered":"UAE\u2019s MGX Joins $2.1B Funding Round for AI  Isomorphic Labs"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>UAE-based MGX participated in Isomorphic Labs\u2019 $2.1 billion Series B funding round, backing one of the leading companies in AI-powered drug discovery.<\/li>\n\n\n\n<li>Isomorphic Labs, spun out of Alphabet\u2019s DeepMind, uses artificial intelligence models to accelerate drug design, reduce development costs, and improve research efficiency.<\/li>\n\n\n\n<li>The deal reflects growing sovereign investor interest in advanced AI applications beyond data centers and chips, especially in biotechnology and healthcare.<\/li>\n<\/ul>\n\n\n\n<p>UAE-based MGX has participated in a major $2.1 billion Series B funding round for Isomorphic Labs, an AI drug discovery company, in a move that reflects growing sovereign investor interest in biotechnology as one of the most promising future applications of artificial intelligence.<\/p>\n\n\n\n<p>Spun out of Alphabet\u2019s DeepMind, Isomorphic Labs is among the companies working to use AI models to accelerate drug design, reduce the cost of treatment development, and improve the efficiency of pharmaceutical research.<\/p>\n\n\n\n<p>MGX\u2019s participation in the round comes as part of a broader strategy to expand its investments across advanced AI sectors. However, what makes this deal notable is that it does not focus on traditional AI infrastructure such as data centers, chips, or large language models. Instead, it targets a more complex and high-impact field: AI-powered drug discovery.<\/p>\n\n\n\n<p>The investment points to a broader shift in how investors view artificial intelligence. AI is no longer seen only as a tool for improving technical efficiency, but as a strategic layer capable of reshaping entire industries, including healthcare and pharmaceuticals.<\/p>\n\n\n\n<p>Through this investment, MGX is betting on a future where algorithms and data become central to scientific research, from analyzing proteins and molecules to designing more accurate and faster therapeutic compounds.<\/p>\n\n\n\n<p>The round also highlights rising global competition in the AI drug discovery sector, as investors increasingly back companies capable of turning artificial intelligence from a supporting technology into an advanced scientific infrastructure that can accelerate the development of new treatments and unlock opportunities across the global pharmaceutical market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UAE-based MGX has participated in a major $2.1 billion Series B funding round for Isomorphic Labs, an AI drug discovery company, in a move that reflects growing sovereign investor interest in biotechnology as one of the most promising future applications of artificial intelligence. Spun out of Alphabet\u2019s DeepMind, Isomorphic Labs is among the companies working [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":65856,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8850],"tags":[3658],"class_list":["post-65858","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-venture","tag-mgx"],"acf":[],"_links":{"self":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts\/65858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/comments?post=65858"}],"version-history":[{"count":1,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts\/65858\/revisions"}],"predecessor-version":[{"id":65859,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts\/65858\/revisions\/65859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/media\/65856"}],"wp:attachment":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/media?parent=65858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/categories?post=65858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/tags?post=65858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}